Labshake search
Citations for Tocris :
751 - 800 of 1099 citations for 6H Pyrido 4 3 b carbazole 9 methoxy 5 6 11 trimethyl since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Bioengineering 2022Quote: ... Y-27632 (10 μM; Seleckchem) and CHIR99021 (5 μM;. Tocris). Jejunal organoids were split every 7 to 9 days as previously described.[112] Based on this established protocol ...
-
bioRxiv - Genomics 2019Quote: ... ER stress was induced by adding 5 µM Tunicamycin (Tocris) for 24 hours.
-
bioRxiv - Neuroscience 2020Quote: ... and D-2-amino-5-phosphonovalerate (APV, 25 µM, Tocris) in order to block synaptic transmission and ensure that the observed events were due to the stimulation only ...
-
bioRxiv - Neuroscience 2021Quote: ... as well as 5 µg/mL insulin (Tocris Bioscience Inc), 1 mM GlutaMAX ...
-
bioRxiv - Neuroscience 2022Quote: ... 50 D-2-amino-5-phosphonopentanoic acid (D-APV) (Tocris), and 10 gabazine (Sigma) ...
-
bioRxiv - Cell Biology 2022Quote: ... TGF-β inhibitor A 83-01 (5 uM, Tocris bioscience), VEGF-121 (10 ng/mL ...
-
bioRxiv - Neuroscience 2020Quote: ... and D(-)-2-Amino-5-phosphonopentanoic acid (D-AP5, Tocris) was prepared as 50 mM stocks dissolved in 30% 1 M NaOH ...
-
bioRxiv - Neuroscience 2020Quote: ... DL-2-Amino-5-phosphonopentanoic acid (APV, 50 μM, Tocris) was added to the ACSF to avoid the unintended N-methyl-D-aspartate receptor (NMDAR ...
-
bioRxiv - Neuroscience 2019Quote: ... 200µM D-(-)-2-Amino-5-phosphonopentanoic acid (D-AP5, Tocris). All these compounds were applied in the recording chamber for at least 10 minutes before continuing measurements ...
-
bioRxiv - Neuroscience 2021Quote: ... α,β-methyleneadenosine 5’-triphosphate trisodium salt (TOCRIS: Cat. 3209), hydrochloride were dissolved into 100 mM stock in Milli-Q water and further diluted into different concentrations ...
-
bioRxiv - Cancer Biology 2022Quote: ... alone or with 5 μM AR-C118925XX (AR-C, Tocris) or 10 μM cycloRGDfV (cRGDfV ...
-
bioRxiv - Neuroscience 2022Quote: ... XAV939 (5 μM; catalog#3748, Tocris Bioscience, Bristol, United Kingdom), PD0325901 (1 μM ...
-
bioRxiv - Neuroscience 2019Quote: ... the selective D3 receptor antagonist SB 27701A (5 µM; Tocris); the selective D4 receptor antagonist L-745 ...
-
bioRxiv - Neuroscience 2021Quote: ... and d-2-amino-5-phosphonopentanoic acid (D-AP5) (Tocris). Drugs were prepared as concentrated stock solutions and were diluted in ACSF on the day of the experiment.
-
bioRxiv - Neuroscience 2020Quote: ... saturated with 95 % O2/5 % CO2 (drugs from Tocris Bioscience). 3–6 MΩ borosilicate pipettes were filled with intracellular solution (containing in mM ...
-
bioRxiv - Cell Biology 2022Quote: ... resuspended in 5% FBS + 0.5% BSA + 10mm Y-27632 (Tocris) in PBS and sorted for viability by exclusion of Sytox Blue dead cell stain (Thermo Fisher Scientific ...
-
bioRxiv - Cancer Biology 2022Quote: ... or adenosine 5’-[γ-thio]triphosphate tetralithium salt (ATPγS, Tocris) alone or with 5 μM AR-C118925XX (AR-C ...
-
bioRxiv - Neuroscience 2023Quote: ... 20 L-AP4 (Alomone Labs) and 2-5 ACET (Tocris) (Park et al. ...
-
bioRxiv - Neuroscience 2023Quote: ... Step 2: synaptic blockers (50µm DL-AP-5 (Tocris #0105), 40µm L-AP4 (Tocris #0103) ...
-
bioRxiv - Cancer Biology 2023Quote: ... TGF-β inhibitor A 83-01 (5 uM, Tocris bioscience), Fungin (10μg/ml ...
-
bioRxiv - Bioengineering 2024Quote: ... 5 μM Y-27632 dihydrochloride (Tocris Bioscience, cat. no. 1254), a rho-associated protein kinase (ROCK ...
-
bioRxiv - Neuroscience 2024Quote: ... and 2-amino-5-phosphonovaleric acid (APV, 50 μM, Tocris) for blockade of NMDAR-mediated responses ...
-
bioRxiv - Cancer Biology 2021Quote: ... the positive control consisted of a treatment with 1 μM 3-AP (#2251; Tocris) for 72 h.
-
bioRxiv - Molecular Biology 2020Quote: Wild type zebrafish were exposed to 3 μM JWH-018 (Tocris, Cat. No. 1342), from 24 hours to six days post fertilization (dpf) ...
-
bioRxiv - Developmental Biology 2023Quote: ... but on day 3 medium was changed for LY (1 µM LPA (Tocris, 3854) and 10 µM ROCKi Y27632 ...
-
bioRxiv - Cell Biology 2023Quote: ... For the next 3 days CDBM with 0,6U/ml heparin and 3mM IWP2 (Tocris) was refreshed daily ...
-
bioRxiv - Neuroscience 2023Quote: ... mice were intraperitoneally injected with either 3 mg per kg of scopolamine hydrobromide (Tocris) dissolved in saline or vehicle (saline) ...
-
bioRxiv - Neuroscience 2024Quote: ... postsynaptic pharmacology experiments utilized nAChR antagonists dihydro-β-erythroidine hydrobromide (DHβE, 3 μM, Tocris) and methyllycaconitine (MLA ...
-
bioRxiv - Neuroscience 2021Quote: ... The resulting cell pellet was broken up and resuspended in 1ml E8 media by 1000ul pipette and distributed on a Geltrex coated 6 well plate with E8 and 10µM ROCK inhibitor (Y-27632 dihydrochloride, Tocris) for 24 hours ...
-
bioRxiv - Neuroscience 2020Quote: ... and re-plated at 1:6 ratio on Matrigel-coated plate in neural medium supplemented with 1μM CHIR99021 (Tocris), 2μM DMH1 (Tocris) ...
-
bioRxiv - Neuroscience 2020Quote: ... and re-plated at 1:6 ratio on Matrigel-coated plate in neural medium supplemented with 3μM CHIR99021 (Tocris), 2μM DMH1 (Tocris) ...
-
bioRxiv - Cell Biology 2021Quote: ... or the AMPA-iGluR specific inhibitor 2,3-dioxo-6-nitro-7-sulfamoyl-benzo[f]quinoxaline (NBQX, cat. num. 373, Tocris). Drugs were dissolved in ESC complete media (no 2i ...
-
bioRxiv - Neuroscience 2022Quote: ... were recorded during the application of the competitive AMPA/kainate receptor antagonist 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX; 20 μM, Tocris) and the selective NMDA receptor antagonist amino-5-phosphonopentanoic acid (AP5 ...
-
bioRxiv - Neuroscience 2019Quote: ... in the presence of the mGluR5 antagonist 2-methyl-6 (phenylethynyl)-pyridine (MPEP, 25 μM; Tocris Bioscience, Bristol, UK). Inhibitors were applied concomitantly from 30 min before to 30 min after DHPG/MPEP treatment ...
-
bioRxiv - Neuroscience 2019Quote: ... 2,3-Dioxo-6-nitro-1,2,3,4-tetrahydrobenzo[f]quinoxaline-7-sulfonamide (“NBQX”, 100 mM in DMSO, Tocris Cat No 0373); D-2-amino-5-phosphonovalerate (“D-AP5” ...
-
bioRxiv - Neuroscience 2021Quote: ... The mGluR5 specific negative allosteric modulator MPEP hydrochloride (2-Methyl-6-(phenylethynyl)pyridine hydrochloride) was purchased from Tocris (1212) and administered to brain slices at 30 μM by bath perfusion ...
-
bioRxiv - Molecular Biology 2022Quote: ... 6 replicates of each condition were treated with DMSO or 100 nM dTAG13 (Tocris Bioscience, Fisher Scientific 66-055) for 2 hours ...
-
bioRxiv - Neuroscience 2022Quote: ... drugs were bath applied at the following concentrations (in μM): 10 6-Cyano-7-nitroquinoxaline-2,3-dione disodium salt (CNQX, Tocris), 50 D-2-amino-5-phosphonopentanoic acid (D-APV ...
-
bioRxiv - Cell Biology 2022Quote: ... Neuroectoderm was induced for 6 days in CDM-BSA supplemented with 12ng/ml FGF2 and 10μM SB431542 (Activin/Nodal/TGFβ inhibitor; Tocris), as previously described34 ...
-
bioRxiv - Immunology 2023Quote: Co-culture assays: thymocytes were isolated from untreated C57BL/6 mice and incubated with Nigericin (10 µM, Tocris, 4312) and LPS (1 ng/ml ...
-
Sexual differences in neuronal and synaptic properties across subregions of the mouse insular cortexbioRxiv - Neuroscience 2023Quote: ... were recorded at −70mV in presence of 20□μM CNQX (6-Cyano-7-nitroquinoxaline-2,3-dione disodium, an AMPA receptor antagonist, Tocris) and L-APV 50 μM (DL-2-Amino-5-phosphonopentanoic acid ...
-
bioRxiv - Neuroscience 2024Quote: ... were recorded at −70mV in presence of 10□μM CNQX (6-Cyano-7-nitroquinoxaline-2,3-dione disodium, an AMPA receptor antagonist, Tocris) and L-APV 50 μM (DL-2-Amino-5-phosphonopentanoic acid ...
-
bioRxiv - Neuroscience 2021Quote: ... L-(+)-2-amino-4-phosphonobutyric acid (L-AP4, 50 μM, Tocris Bioscience), were freshly diluted and bath-applied through the perfusion line 10 minutes before recording ...
-
bioRxiv - Cell Biology 2021Quote: ... CBA (4-chloro-2-[[2-(2-chlorophenoxy) acetyl aminobenzoic acid from Tocris Bioscience (Minneapolis ...
-
bioRxiv - Neuroscience 2020Quote: ... Cultures treated for 4 h with NMDA (50 μg/ml; Tocris #0114) and cultures incubated for 2 h with PI after fixation (referred to as ‘post-fixation’ ...
-
bioRxiv - Neuroscience 2022Quote: ... Cultures treated for 4 h with NMDA (50 μg/ml; #0114 Tocris) served as positive controls in these experiments ...
-
bioRxiv - Neuroscience 2023Quote: ... we tested effects of an inhibitor (the spider toxin GsMTX 4; Tocris #4912 stock 50 μM in DMSO and the Piezo1 channel activator Yoda1 (Tocris 6586 10 and 20 uM ...
-
bioRxiv - Bioengineering 2024Quote: ... CDM was supplemented with 4 μM CHIR99021 (Tocris Bioscience, cat. no. 4423), and from day 2 to day 4 ...
-
bioRxiv - Neuroscience 2021Quote: ... the OXT antagonist L-368,899 hydrochloride (Tocris Biosciences, 2641, 5 μM) and agonist WAY 267464 dihydrochloride (Tocris Biosciences ...
-
bioRxiv - Bioengineering 2021Quote: ... and TGF-βinhibitor (SB431542, Tocris, 1614, 5 µM, days 0-10). On Day 2 ...